Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/SC/Mauldin
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Mauldin, SC

Studies commonly pay $75 to $4,500 per completed study

378 clinical trials are currently recruiting participants within 30 miles of Mauldin. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

378studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Mauldin right now

Top 25 of 378 recruiting studies, sorted by proximity — each links to its official registry page

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (7.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Gibbs Cancer Center-Pelham — Greer, South Carolina (11.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
Bon Secours - St. Francis Hospital — Greenville, South Carolina (7.1 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Triple Negative Breast Cancer, HER2-negative Breast Cancer Phase 1 Interventional 96 participants sought
Dren Investigational Site — Greenville, South Carolina (7.1 mi) · Sponsor: Dren Bio
See eligibility & contact on ClinicalTrials.gov (NCT06999187)

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Chronic Inducible Urticaria, Cold Urticaria Phase 3 Interventional 240 participants sought
Advanced Dermatology and Cosmetic Surgery - Spartanburg — Spartanburg, South Carolina (24.0 mi) · Sponsor: Celldex Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07266402)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (7.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (7.1 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
St Francis Cancer Center /ID# 243596 — Greenville, South Carolina (7.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

Lower Extremity Acute Limb Ischemia, LE ALI N/A Observational 300 participants sought
Prisma Health Greenville Memorial Hospital — Greenville, South Carolina (7.1 mi) · Sponsor: Penumbra Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06747117)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
AnMed Health Medical Center — Anderson, South Carolina (27.6 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
St Francis Cancer Center ( Site 0093) — Greenville, South Carolina (7.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06966700)

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Rhinovirus Infection Phase 2 Interventional 180 participants sought
Velocity Clinical Research - Spartanburg — Spartanburg, South Carolina (24.0 mi) · Sponsor: Altesa Biosciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07610395)

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (7.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04166409)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (7.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05382338)

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Sickle Cell Disease Phase 2, Phase 3 Interventional 389 participants sought
Prisma Health Hillcrest Hospital — Simpsonville, South Carolina (4.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05431088)

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

RSV Infection Phase 3 Interventional 550 participants sought
Prisma Health Maternal Fetal Medicine — Greenville, South Carolina (7.1 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06866405)

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Type 2 Diabetes, Cortisol Excess Phase 2 Interventional 1,500 participants sought
Velocity Clinical Research, Anderson — Anderson, South Carolina (27.6 mi) · Sponsor: Sparrow Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07296484)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought
Saint Francis Health System ( Site 0089) — Greenville, South Carolina (7.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT03486873)

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder N/A Observational 2,240 participants sought
Saint Francis Hospital — Greenville, South Carolina (7.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04242095)

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Advanced Solid Tumors Phase 1 Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (7.1 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05719558)

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Opioid Use Disorder, Opioid Use Disorder, Moderate Phase 2 Interventional 310 participants sought
Prisma Health — Greenville, South Carolina (7.1 mi) · Sponsor: T. John Winhusen, PhD
See eligibility & contact on ClinicalTrials.gov (NCT06651177)

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer Phase 1 Interventional 120 participants sought
Prisma Health Cancer Institute — Greenville, South Carolina (7.1 mi) · Sponsor: SystImmune Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07080242)
Actively enrolling

Studies you may be able to join near Mauldin

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Mauldin

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

The Research Center of the Upstate

★ 5.0
2086 Woodruff Rd, Greenville, SC 29607
(864) 626-3117
"Amazing and knowledgeable staff. Research program much needed in our local community."
— Victor & Rene' Pressley, 5★

Tribe Clinical Research

★ 4.9
545 Verdae Blvd Ste B, Greenville, SC 29607
(864) 334-0141
"The staff here makes sure you are well informed and comfortable with the trial that you are participating in. Questions are welcomed and answered In …"
— amy bellis, 5★

ADAC Research, PA

★ 3.5
1202 E Butler Rd, Greenville, SC 29607
(864) 627-3800 ext. 221
"They were rude and you have to set a timer your self,and they dropped the cotton swabs in the trash,and still put the creem on with the contaminated …"
— Kippy Sloan, 1★

Palmetto Clinical Trial Services, LLC

37 Brendan Way, Greenville, SC 29615
(864) 214-1217

Tribe Clinical Research

312 Harrison Bridge Rd A, Simpsonville, SC 29680
(864) 334-0141

Hillcrest Clinical Research

717 SE Main St Ste B, Simpsonville, SC 29681
(864) 962-5146

Palmetto Clinical Trial Services, LLC

115 N Main St, Fountain Inn, SC 29644
(864) 962-0431

Institute for Translational Oncology Research

900 W Faris Rd, Greenville, SC 29605
(864) 455-3600

Velocity Clinical Research

★ 4.7
141 Harold Fleming Ct, Spartanburg, SC 29303
(864) 515-0092
"Everyone is considerate and explains everything to you."
— Patricia Ponder, 5★

Clinical trials in Mauldin: what's recruiting

The Mauldin area currently has 378 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Mauldin, the most active research areas are:

  • Cancer & Oncology13 studies
  • Heart & Vascular2 studies
  • Lungs & Breathing2 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Mauldin, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Mauldin

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Mauldin participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Mauldin pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Mauldin?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Mauldin safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Mauldin typically complete one or two studies per year.

Paid clinical trials near Mauldin

Other metros within reach

Greenville, SC380 Spartanburg, SC364 Asheville, NC124 Gastonia, NC661 Rock Hill, SC603 Athens, GA75 Hickory, NC94 Augusta, GA185

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Mauldin Chronic Kidney Disease (HealthMatch) in Mauldin Bladder Issues Due To Spinal Cord Injury in Mauldin All conditions

More of SC

Charleston737 Rock Hill603 Greenville380 Spartanburg364 Columbia190 Myrtle Beach92

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts